Ryo Takemura Selected Research

Ryo Takemura Research Topics

Disease

17	Esophageal Squamous Cell Carcinoma 11/2023 - 12/2021
16	Esophageal Neoplasms (Esophageal Cancer) 11/2023 - 12/2020
5	Migraine Disorders (Migraine) 03/2024 - 12/2022
5	Neoplasms (Cancer) 11/2023 - 08/2015
3	Headache (Headaches) 03/2024 - 01/2022
3	Anastomotic Leak 02/2023 - 09/2022
2	Obesity 02/2024 - 01/2024
2	Pulmonary Arterial Hypertension 12/2023 - 04/2023
2	Lymphatic Metastasis 11/2023 - 09/2022
2	Post-Acute COVID-19 Syndrome 11/2023 - 11/2023
2	Pneumonia (Pneumonitis) 02/2023 - 09/2022
2	Residual Neoplasm 04/2022 - 01/2022
2	COVID-19 01/2022 - 01/2022
2	Infections 01/2022 - 11/2021
1	Body Weight (Weight, Body) 02/2024
1	Type 2 Diabetes Mellitus (MODY) 02/2024
1	Abdominal Obesity 02/2024
1	Coronary Artery Disease (Coronary Atherosclerosis) 01/2024
1	Hyperinsulinism (Hyperinsulinemia) 01/2024
1	Open-Angle Glaucoma (Glaucoma, Open Angle) 12/2023
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 10/2023
1	Injection Site Reaction 10/2023
1	Atrial Fibrillation 09/2023
1	Hemorrhage 09/2023
1	Pulmonary Hypertension 04/2023
1	Osteonecrosis (Kienbock's Disease) 02/2023
1	Heart Failure 02/2023
1	Radius Fractures (Radius Fracture) 02/2023
1	Pemphigus (Pemphigus Vulgaris) 02/2023
1	Heart Arrest (Cardiac Arrest) 01/2023
1	Myocarditis (Carditis) 12/2022
1	End Stage Liver Disease 09/2022
1	Sepsis (Septicemia) 09/2022
1	Bronchiolitis Obliterans Syndrome 01/2022
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 12/2021
1	Spinal Cord Diseases 05/2021
1	Hepatocellular Carcinoma (Hepatoma) 02/2021

Drug/Important Bio-Agent (IBA)

3	Calcitonin Gene-Related PeptideIBA 03/2024 - 03/2023
3	Monoclonal AntibodiesIBA 03/2024 - 03/2023
3	Oxygen (Dioxygen)IBA 11/2023 - 01/2022
3	Therapeutic UsesIBA 04/2023 - 01/2023
2	N-acetyltalosaminuronic acid (NAT)IBA 11/2023 - 01/2023
2	fremanezumabIBA 11/2023 - 10/2023
2	galcanezumabIBA 10/2023 - 12/2022
2	AntigensIBA 01/2022 - 06/2008
2	Fibrinogen (Factor I)FDA Link 02/2021 - 12/2020
2	AlbuminsIBA 02/2021 - 12/2020
2	Indicators and Reagents (Reagents)IBA 01/2021 - 08/2015
1	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 02/2024
1	Glucose (Dextrose)FDA LinkGeneric 01/2024
1	NAD (NADH)IBA 01/2024
1	Insulin (Novolin)FDA Link 01/2024
1	Nicotinamide MononucleotideIBA 01/2024
1	Calcium Channel Blockers (Blockers, Calcium Channel)IBA 11/2023
1	Cardiovascular AgentsIBA 10/2023
1	AnticoagulantsIBA 09/2023
1	Fluorouracil (Carac)FDA LinkGeneric 07/2023
1	Docetaxel (Taxotere)FDA Link 07/2023
1	Cisplatin (Platino)FDA LinkGeneric 07/2023
1	satralizumabIBA 04/2023
1	Interleukin-6 (Interleukin 6)IBA 04/2023
1	CytokinesIBA 04/2023
1	Epoprostenol (Prostacyclin)FDA LinkGeneric 04/2023
1	Endothelins (Endothelin)IBA 04/2023
1	Vasodilator Agents (Vasodilators)IBA 04/2023
1	DesmogleinsIBA 02/2023
1	Rituximab (Mabthera)FDA Link 02/2023
1	Immunoglobulin G (IgG)IBA 02/2023
1	Immune Checkpoint InhibitorsIBA 12/2022
1	Troponin IIBA 12/2022
1	BilirubinIBA 09/2022
1	SodiumIBA 09/2022
1	CatecholaminesIBA 09/2022
1	Immunosuppressive Agents (Immunosuppressants)IBA 01/2022
1	Calcineurin InhibitorsIBA 01/2022
1	CarbohydratesIBA 01/2022
1	Messenger RNA (mRNA)IBA 01/2022
1	Tyrosine Kinase InhibitorsIBA 12/2021
1	osimertinibIBA 12/2021
1	Midazolam (Versed)FDA LinkGeneric 02/2021
1	Propofol (Diprivan)FDA LinkGeneric 02/2021
1	HydrogenIBA 01/2021

Therapy/Procedure

17	Neoadjuvant Therapy 11/2023 - 01/2020
13	Esophagectomy 09/2023 - 02/2021
9	Therapeutics 12/2023 - 02/2014
3	Drug Therapy (Chemotherapy) 01/2023 - 02/2014
2	Glycemic Control 02/2024 - 10/2023
2	Transplantation 09/2022 - 01/2022
2	Immunotherapy 12/2021 - 08/2015
1	Intraocular Lenses (Intraocular Lens) 12/2023
1	Operative Surgical Procedures 02/2023
1	Resuscitation 01/2023
1	Operative Time 09/2022
1	Chemoradiotherapy 01/2022
1	Artificial Respiration (Mechanical Ventilation) 01/2022
1	Hematopoietic Stem Cell Transplantation 01/2022
1	Liver Transplantation 11/2021
1	Decompression 05/2021
1	Radiofrequency Ablation 02/2021
1	Pancreatectomy 01/2021